PIL scheme: Govt approves four applications for KSMs/drug intermediaries, APIs

PIL scheme: Govt approves four applications for KSMs/drug intermediaries, APIs
May 31, 2021
Forty six applications with committed investment of ₹5,355.44 crore have been approved so far
The government, on Monday, approved four applications under its production-linked scheme for promotion of the domestic manufacturing of Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).
According to a Chemicals and Fertilizers Ministry statement, Solara Active Pharma Science Limited received approval for 1,1 Cyclohexane Diacetic Acid (CDA) under the chemical synthesis-based KSMs/Drug Intermediates segment, and Rajasthan Antibiotics Ltd received nod for Meropenem Other Chemical Synthesis Based KSMs/Drug Intermediates and APIs.
Similarly, Dhatri Lab Private Ltd has received approval for Ritonavir and Vital Laboratories Private Ltd for Levofloxacin under the segment of Other Chemical Synthesis-based KSMs/Drug Intermediates and APIs. These firms were selected because those companies which originally received the approvals withdrew from the PLI scheme.

Related Keywords

,Rajasthan Antibiotics Ltd ,Dhatri Lab Private Ltd ,Vital Laboratories Private Ltd For Levofloxacin ,Solara Active Pharma Science ,Fertilizers Ministry ,Key Starting Materials ,Drug Intermediates ,Active Pharmaceutical Ingredients ,Solara Active Pharma Science Limited ,Diacetic Acid ,Vital Laboratories Private Ltd ,Wait List ,Tapi ,Pli ,Intermediaries ,Drug ,Government ,சோலாரா செயலில் பார்மா அறிவியல் ,உரங்கள் அமைச்சகம் ,விசை தொடங்குகிறது பொருட்கள் ,மருந்து இடைத்தரகர்கள் ,செயலில் மருந்து பொருட்கள் ,சோலாரா செயலில் பார்மா அறிவியல் வரையறுக்கப்பட்டவை ,காத்திரு பட்டியல் ,அபி ,ப்லை ,இடைத்தரகர்கள் ,மருந்து ,அரசு ,